Suppr超能文献

[1例晚期肝细胞癌患者,口服优福定后肿瘤几乎消失]

[A case of advanced hepatocellular carcinoma, in which the tumor almost disappeared by orally administered UFT].

作者信息

Miyagawa H, Kamioka N, Kohara H, Yuube R, Takahashi T, Nakatoh H, Kawada M, Utsunomiya T, Izumiyama F, Akimori T

机构信息

Dept. of Internal Medicine, Kouchi Municipal Hospital of Aki.

出版信息

Gan To Kagaku Ryoho. 1993 Nov;20(14):2211-5.

PMID:8239687
Abstract

A 59-year-old male with liver cirrhosis was admitted to our hospital for further examination of general fatigue. A huge tumor was found in the right lobe of his liver with abdominal ultrasonography and computed tomography (CT). The titers of serum AFP (14,055 ng/ml) and PIVKA-II (more than 50.0 AU/ml) were extremely high. A tumor embolus was observed in the portal vein with abdominal angiography. According to these findings, he was diagnosed as having advanced hepatocellular carcinoma (HCC). He was treated by oral administration of UFT (600 mg/day) as an unresectable case of HCC. Three months later, the clinical symptoms were greatly improved and HCC was almost diminished with abdominal ultrasonography and CT, although a small tumor embolus was found by angiography. The titers of AFP and PIVKA-II were reduced to the normal range. This case suggests the clinical effectiveness of UFT for the treatment of HCC.

摘要

一名59岁的肝硬化男性因全身乏力入院接受进一步检查。通过腹部超声和计算机断层扫描(CT)发现其肝脏右叶有一个巨大肿瘤。血清甲胎蛋白(AFP)水平(14,055纳克/毫升)和异常凝血酶原(PIVKA-II)水平(超过50.0 AU/毫升)极高。腹部血管造影显示门静脉有肿瘤栓子。根据这些检查结果,他被诊断为晚期肝细胞癌(HCC)。作为无法切除的HCC病例,他接受了口服优福定(UFT,600毫克/天)治疗。三个月后,临床症状明显改善,腹部超声和CT检查显示HCC几乎消失,尽管血管造影发现有一个小的肿瘤栓子。AFP和PIVKA-II水平降至正常范围。该病例表明优福定对HCC治疗具有临床有效性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验